Randomised feasibility trial to compare three standard of care chemotherapy regimens for early stage triple-negative breast cancer (REaCT-TNBC trial).
John HiltonCarol StoberSasha MazzarelloLisa VandermeerDean FergussonBrian HuttonMark ClemonsPublished in: PloS one (2018)
ClinicalTrials.gov NCT02688803.